| Title : Main metabolic pathways of TAK-802, a novel drug candidate for voiding dysfunction, in humans: the involvement of carbonyl reduction by 11beta-hydroxysteroid dehydrogenase 1 - Nishihara_2014_Drug.Res.(Stuttg)_64_476 |
| Author(s) : Nishihara M , Takahashi J , Kondo T , Mouri K , Asahi S |
| Ref : Drug Res (Stuttg) , 64 :476 , 2014 |
| Abstract : Nishihara_2014_Drug.Res.(Stuttg)_64_476 |
| ESTHER : Nishihara_2014_Drug.Res.(Stuttg)_64_476 |
| PubMedSearch : Nishihara_2014_Drug.Res.(Stuttg)_64_476 |
| PubMedID: 24357138 |
Nishihara M, Takahashi J, Kondo T, Mouri K, Asahi S (2014)
Main metabolic pathways of TAK-802, a novel drug candidate for voiding dysfunction, in humans: the involvement of carbonyl reduction by 11beta-hydroxysteroid dehydrogenase 1
Drug Res (Stuttg)
64 :476
Nishihara M, Takahashi J, Kondo T, Mouri K, Asahi S (2014)
Drug Res (Stuttg)
64 :476